Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Park Aerospace
PKE
$737M
| $55.5K | ﹤0.01% |
4,025
-5,939
| -60% | -$78.6K |
|
3627
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
| $55.3K | ﹤0.01% |
+250
| New | +$49.4K |
|
3628
SEACOR Marine Holdings
SMHI
$256M
| $55.1K | ﹤0.01% |
4,823
-3,373
| -41% | -$29.9K |
|
3629
Kodak
KODK
$822M
| $55.1K | ﹤0.01% |
11,921
-17,065
| -59% | -$72K |
|
3630
Jakks Pacific
JAKK
$301M
| $55K | ﹤0.01% |
2,756
-7,683
| -74% | -$166K |
|
3631
Tucows
TCX
$172M
| $54.8K | ﹤0.01% |
1,976
-3,035
| -61% | -$78.3K |
|
3632
PepGen
PEPG
$122M
| $54.8K | ﹤0.01% |
6,126
-1,529
| -20% | -$20K |
|
|
PSTL
3633
Postal Realty Trust
PSTL
$694M
| $54.8K | ﹤0.01% |
3,722
-5,398
| -59% | -$79.8K |
|
3634
Limoneira
LMNR
$235M
| $54.7K | ﹤0.01% |
3,518
-5,043
| -59% | -$83.1K |
|
|
LGHL
3635
Lion Group Holding
LGHL
$853K
| – | – |
0
| – | – |
|
3636
Unilever
UL
$137B
| $54.7K | ﹤0.01% |
932
-40
| -4% | -$2.38K |
|
|
ICVX
3637
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $54.4K | ﹤0.01% |
5,480
-7,611
| -58% | -$60.9K |
|
3638
Global X Uranium ETF
URA
$5.42B
| $54.4K | ﹤0.01% |
2,505
-3,465
| -58% | -$70.9K |
|
3639
Ascendis Pharma A/S
ASND
$16B
| $54.3K | ﹤0.01% |
608
-68,294
| -99% | -$5.94M |
|
3640
Outlook Therapeutics
OTLK
$183M
| $53.9K | ﹤0.01% |
1,548
-2,412
| -61% | -$65.8K |
|
3641
Hamilton Beach Brands
HBB
$311M
| $53.6K | ﹤0.01% |
5,551
| – | – |
|
|
FRBK
3642
DELISTED
Republic First Bancorp Inc
FRBK
| $53.6K | ﹤0.01% |
59,543
-61,553
| -51% | -$70.4K |
|
|
HTZWW
3643
Hertz Global Holdings Warrants
HTZWW
$66M
| $53.6K | ﹤0.01% |
5,310
-4
| -0.1% | -$36 |
|
3644
Tenaya Therapeutics
TNYA
$161M
| $53.5K | ﹤0.01% |
9,122
-20,877
| -70% | -$121K |
|
|
CONN
3645
DELISTED
Conn's Inc.
CONN
| $53.3K | ﹤0.01% |
14,396
-2,711
| -16% | -$12.3K |
|
3646
StealthGas
GASS
$332M
| $53.3K | ﹤0.01% |
12,500
| – | – |
|
3647
Energy Vault
NRGV
$517M
| $53.2K | ﹤0.01% |
19,501
-21,913
| -53% | -$46.1K |
|
|
PTRA
3648
DELISTED
Proterra Inc. Common Stock
PTRA
| $52.9K | ﹤0.01% |
44,060
-69,103
| -61% | -$84.9K |
|
3649
Banco Macro
BMA
$5.88B
| $52.8K | ﹤0.01% |
+2,000
| New | +$40K |
|
3650
System1
SST
$14.3M
| $52K | ﹤0.01% |
+1,156
| New | +$43.7K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.